Gastric cancer
2025 · The Lancet · 132 citations
https://doi.org/10.1016/s0140-6736(25)00052-2
I
Izuma Nakayama
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
210
Papers
1.6K
Citations
18
h-index
39
i10-index
Izuma Nakayama is an academic researcher from National Cancer Centre Japan. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Colorectal Cancer Treatments and Studies & Gastrointestinal Tumor Research and Treatment. The author has an h-index of 18, co-authored 179 publications.
ORCID: 0000-0003-4987-1934Papers by this author
worksClinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer
2018 · Journal of Gastroenterology · 100 citations
https://doi.org/10.1007/s00535-018-1464-0
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer
2024 · ESMO Open · 79 citations
https://doi.org/10.1016/j.esmoop.2023.102226
Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer
2018 · Gastric Cancer · 72 citations
https://doi.org/10.1007/s10120-018-0887-x
Whole‐transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential
2024 · Cancer Science · 18 citations
https://doi.org/10.1111/cas.16109
A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care
2021 · ESMO Open · 15 citations
https://doi.org/10.1016/j.esmoop.2021.100234
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat